financetom
Business
financetom
/
Business
/
BRIEF-Neinor secures €225mln with record €1.2bln demand to fund the AEDAS Tender Offer acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Neinor secures €225mln with record €1.2bln demand to fund the AEDAS Tender Offer acquisition
Jun 25, 2025 5:40 AM

June 25 (Reuters) - Neinor Homes SA:

* NEINOR SECURES €225MN WITH RECORD €1.2BN DEMAND TO FUND

THE

AEDAS TENDER OFFER ACQUISITION

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JPMorgan expects 2024 interest income to rise to $91 billion
JPMorgan expects 2024 interest income to rise to $91 billion
May 20, 2024
NEW YORK, May 20 (Reuters) - JPMorgan Chase's ( JPM ) net interest income (NII), or the difference between what it makes on loans and pays out on deposits, will rise to $91 billion, excluding markets, this year, the bank said in an investor presentation on Monday. ...
Electric Scooter Company Niu Tech Stock Falls After Q1 Print, Read The Details
Electric Scooter Company Niu Tech Stock Falls After Q1 Print, Read The Details
May 20, 2024
Niu Technologies ( NIU )  reported a fiscal first-quarter 2024 revenue growth of 21.0% to 504.7 million Chinese yuan ($69.91 million), mainly due to an increase in sales volume of 36.8% partially offset by a decrease in revenues per e-scooter of 11.6%. The company reported earnings per ADS of $(0.10). Adjusted net loss was CNY (48.5) million versus CNY (46.1) million a year ago. The stock price declined after...
JPMorgan raises 2024 interest income forecast to $91 billion
JPMorgan raises 2024 interest income forecast to $91 billion
May 20, 2024
NEW YORK (Reuters) -JPMorgan Chase ( JPM ) on Monday raised its forecast for net interest income (NII), or the difference between what it makes on loans and pays out on deposits, to $91 billion, excluding the markets division. Shares of the bank rose about 1% in premarket trading ahead of the bank's investor day event scheduled to kick off...
Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results
Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results
May 20, 2024
06:47 AM EDT, 05/20/2024 (MT Newswires) -- Amgen ( AMGN ) and AstraZeneca ( AZN ) said late Sunday that the Phase 2a trial of their experimental drug, Tezspire, to treat moderate to very severe chronic obstructive pulmonary disease (COPD) did not show a statistically significant reduction in the severity of the disease compared to placebo. The data, when compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved